|
|
Application value of diffusion weighted imaging eADC value in differential diagnosis of benign and malignant prostatic nodules |
LIU Sanchun1 QI Ying1 ZHOU Zhihuai1 YANG Xuezhen2 |
1.Department of Radiology, the Second Affiliated Hospital of Bengbu Medical College, Anhui Province, Bengbu 233040, China;
2.Department of Urinary Surgery, the Second Affiliated Hospital of Bengbu Medical College, Anhui Province, Bengbu 233040, China |
|
|
Abstract Objective To investigate the feasibility of differential diagnosis of benign and malignant prostate nodules by the exponential apparent dispersion coefficient (eADC) of magnetic resonance imaging (MRI) diffusion weighted imaging (DWI). Methods From November 2016 to July 2019, 50 prostate cancer patients and 50 benign prostatic hyperplasia patients were selected for MRI DWI examination in the Second Affiliated Hospital of Bengbu Medical College, all of which were confirmed by pathology. DWI signal, apparent diffusion coefficient (ADC) value and eADC value of benign and malignant prostate lesions were compared and analyzed. The receiver operating characteristic curve (ROC) was used to obtain the optimal diagnostic cut-off points of ADC and eADC. Results In the 50 patients with benign prostatic hyperplasia, the hyperplasia nodules were located in the central zone and the transitional zone, and the T2 lipid pressure presented heterogeneous mixed signals with unclear boundaries. DWI showed equal or slightly higher signals, ADC image showed slightly higher signals, and eADC image showed low signals. Among the 50 patients with prostate cancer, cancer nodules were located in the peripheral zone in 12 cases, central zone in 7 cases, translobular growth in 5 cases, multiple nodules in 6 cases, diffuse growth in 20 cases, bone metastasis in 2 cases, bone metastasis plus lymph node metastasis in 1 case. The T2 lipid pressure of the cancer nodule presented low or slightly low signal, most of the boundary was clear, DWI showed high or slightly high signal, ADC image showed significantly low signal, and eADC image showed high signal. The mean ADC image value of prostate cancer was lower than that of benign prostatic hyperplasia, and the difference was highly significant (P < 0.01). ADC value was 1.245×10-3 mm2/s as the best diagnostic threshold, with a sensitivity of 94.6% and specificity of 90.0%. The mean value of eADC of prostate cancer was higher than that of benign prostatic hyperplasia, and the difference was highly significant (P < 0.01). The threshold value of eADC was 0.395, with a sensitivity of 95.2% and specificity of 91.5%. The diagnostic efficacy of ADC and eADC was close. Conclusion The eADC image has similar efficacy with ADC image, eliminates the T2 transmission effect and improves tissue contrast, making it a more valuable reference for the evaluation of prostate cancer.
|
|
|
|
|
[1] 郭文彬.磁共振T2WI与DWI联合成像在前列腺癌诊断中的临床价值[J].中外医疗,2019,38(15):190-192.
[2] 窦保奎,赵晓星,陈维亮.3.0T磁共振扩散张量成像对前列腺癌的诊断价值[J].世界最新医学信息文摘,2019,19(50):4-7.
[3] Sprinkart AM,Marx C,Tr?覿ber F,et al. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer [J]. Rofo,2018,190(8):758-766.
[4] Franiel T,Quentin M,Mueller-Lisse UG,et al. MRI of the Prostate: Recommendations on Patient Preparation and Scanning Protocol [J]. Rofo,2017,189(1):21-28.
[5] 杜红娣,李振凯,尚海龙,等.磁共振表观扩散系数联合tPSA在前列腺疾病诊断中的应用研究[J].南通大学学报:医学版,2018,38(6):484-485.
[6] 詹利平,陈琼英.多参数MRI影像特征对前列腺良恶性结节诊断价值分析[J].中国煤炭工业医学杂志,2018,21(5):502-505.
[7] Park SY,Kim CK,Park JJ,et al. Exponential apparent diffusion coefficient in evaluating prostate cancer at 3T:preliminary experience [J]. Br J Radiol,2016,89(1058):20 150 470.
[8] 冉允宏,赖燕,李明英,等.表观弥散系数联合磁共振弥散加权成像在前列腺增生与前列腺癌中的诊断价值分析[J].实用医院临床杂志,2018,15(5):92-95.
[9] 林军,张志炎,郑攀丰,等.MR弥散加权成像表观弥散系数在前列腺疾病诊断中的应用[J].中国CT和MRI杂志,2019,17(2):54-56,108.
[10] 陆晶,谭颖.盆腔磁共振EPI扩散加权成像在老年前列腺癌中的诊断价值[J].医疗装备,2018,31(5):54-55.
[11] 徐忠军,刘胜,胡路女,等.3.0T磁共振DWI成像在鉴别诊断前列腺良恶性病变中的临床价值[J].中国当代医药,2018,25(24):103-105,111.
[12] Tamada T,Huang C,Ream JM,et al. Apparent Diffusion Coefficient Values of Prostate Cancer: Comparison of 2D and 3D ROIs [J]. AJR Am J Roentgenol,2018,210(1):113-117.
[13] Skorpil M,Brynolfsson P,Engstr?觟m M. Motion corrected DWI with integrated T2-mapping for simultaneous estimation of ADC,T2-relaxation and perfusion in prostate cancer [J]. Magn Reson Imaging,2017,39:162-167.
[14] Wu X,Reinikainen P,Kapanen M,et al. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer[J]. Anticancer Res,2017,37(9):5027-5032.
[15] Lee DH,Nam JK,Jung HS,et al. Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer? [J]. Investig Clin Urol,2017,58(5):324-330.
[16] Barbieri S,Br?觟nnimann M,Boxler S,et al. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI [J]. Eur Radiol,2017, 27(4):1547-1555.
[17] Scialpi M,Martorana E,Aisa MC,et al. Score 3 prostate lesions: a gray zone for PI-RADS v2[J]. Turk J Urol,2017,43(3):237-240.
[18] Zhang YL,Yu BL,Ren J,et al. EADC Values in Diagnosis of Renal Lesions by 3.0T Diffusion-Weighted Magnetic Resonance Imaging:Compared with the ADC Values [J]. Appl Magn Reson,2013,44(3):349-363.
[19] Cou?觡ago F, Sancho G,Catalá V,et al. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy:What radiation oncologists need to know [J]. World Journal of Clinical Oncology,2017,8(4):305-319.
[20] Zhou H,Hallac RR,Yuan Q,et al. Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer [J]. Diagnostics(Basel),2017,7(3):pii:E48. |
|
|
|